» Articles » PMID: 21454956

Total Numbers of Undiagnosed Carriers of Hepatitis C and B Viruses in Japan Estimated by Age- and Area-specific Prevalence on the National Scale

Overview
Journal Intervirology
Specialty Microbiology
Date 2011 Apr 2
PMID 21454956
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To estimate total numbers of undiagnosed carriers of hepatitis C virus (HCV) and hepatitis B virus (HBV) in Japan.

Methods: Area- and age-specific prevalence of HCV as well as HBV was determined in the first-time blood donors [20-39 years (n = 2,429,364)] and examinees of periodical health check-ups [40-74 years (6,204,968 for HCV and 6,228,967 for HBV)] in Japan. Prevalence in adolescents [5-19 years (79,256 for HCV and 68,792 for HBV)] was determined in a single prefecture, and that of HCV in the elderly (≥ 75 years) was estimated by the exponential model. HBV infection was determined by the detection of hepatitis B surface antigen, and HCV infection by either the algorithm or assuming persistent infection in 70% of the individuals with antibody to HCV.

Results: Of the total population of 127,285,653 in 2005, 807,903 (95% CI 679,886-974,292) were estimated to be infected with HCV at a carrier rate of 0.63%, and 903,145 (837,189-969,572) with HBV at that of 0.71%.

Conclusion: Accurate estimation of undiagnosed HCV and HBV carriers in the general population would help to predict the future burden of liver disease, and take appropriate measures for improving healthcare.

Citing Articles

Association of occupational physical activity and sedentary behaviour with the risk of hepatocellular carcinoma: a case-control study based on the Inpatient Clinico-Occupational Database of Rosai Hospital Group.

Nakazawa S, Fukai K, Sano K, Furuya Y, Hoshi K, Kojimahara N BMJ Open. 2025; 15(3):e092020.

PMID: 40074261 PMC: 11904348. DOI: 10.1136/bmjopen-2024-092020.


Candidate Screening for Heart Failure With Preserved Ejection Fraction Clinic by Fib-4 Index From Subclinical Subjects.

Okamoto C, Tsukamoto O, Hasegawa T, Hitsumoto T, Matsuoka K, Amaki M Gastro Hep Adv. 2024; 2(2):170-181.

PMID: 39132617 PMC: 11307393. DOI: 10.1016/j.gastha.2022.09.005.


Metabolic dysfunction-associated fatty liver disease is associated with an increase in systolic blood pressure over time: linear mixed-effects model analyses.

Mori K, Tanaka M, Hosaka I, Mikami T, Endo K, Hanawa N Hypertens Res. 2023; 46(5):1110-1121.

PMID: 36717630 DOI: 10.1038/s41440-023-01179-0.


Preoperative inflammatory markers as prognostic predictors after hepatocellular carcinoma resection: data from a western referral center.

Silva J, Coelho F, Cassenote A, Jeismann V, Fonseca G, Pirola Kruger J BMC Surg. 2022; 22(1):329.

PMID: 36056350 PMC: 9440527. DOI: 10.1186/s12893-022-01779-6.


Burden of chronic hepatitis B and C infections in 2015 and future trends in Japan: A simulation study.

Tanaka J, Kurisu A, Ohara M, Ouoba S, Ohisa M, Sugiyama A Lancet Reg Health West Pac. 2022; 22:100428.

PMID: 35637862 PMC: 9142742. DOI: 10.1016/j.lanwpc.2022.100428.